Oisin Biotechnologies Company
DNA-targeted intervention to clear senescent cells
Technology:
Geroscience
Industry:
Gene Therapy
Headquarters:
Seattle, Washington, United States
Founded Date:
2014
Employees Number:
11-50
Funding Status:
Seed
Investors Number:
6
Total Funding:
7.1M
Last Funding Date:
May 27, 2021
Last Funding Type:
seed round
Register and Claim Ownership